"Carl Zeiss has exclusive rights to Optiscan’s neurosurgery, ear, nose, throat and spine applications."
Now this is the part that many people would want to see pursued, the ENT and spinal applications.
Given that CZM have developed a surgical robot with Convivo attached, why wouldn't they want to expand and market it for other potential applications?
- Forums
- ASX - By Stock
- OPTISCAN - A RETROSPECTIVE
"Carl Zeiss has exclusive rights to Optiscan’s neurosurgery,...
Featured News
Add OIL (ASX) to my watchlist
|
|||||
Last
14.5¢ |
Change
-0.010(6.45%) |
Mkt cap ! $121.1M |
Open | High | Low | Value | Volume |
15.0¢ | 15.0¢ | 14.5¢ | $18.73K | 125.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 62525 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 8061 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 62525 | 0.145 |
5 | 85640 | 0.140 |
4 | 232250 | 0.135 |
3 | 110050 | 0.130 |
6 | 153151 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.155 | 8061 | 2 |
0.165 | 78084 | 1 |
0.170 | 60000 | 2 |
0.175 | 71000 | 1 |
0.180 | 318670 | 8 |
Last trade - 11.40am 14/06/2024 (20 minute delay) ? |
|
|||||
Last
14.5¢ |
  |
Change
-0.010 ( 6.45 %) |
|||
Open | High | Low | Volume | ||
14.5¢ | 14.5¢ | 14.5¢ | 12503 | ||
Last updated 12.17pm 14/06/2024 ? |
Featured News
OIL (ASX) Chart |